Published in Cancer Weekly, March 29th, 2005
Laboratory experiments in human breast cancer cells suggest that the compound inhibits the constant activation of a protein called Stat3 that is found in several different types of cancer, including cancer of the breast, lung, prostate, head and neck, skin, pancreas, and ovaries as well as lymphoma and certain kinds of leukemia.
Stat3 is constantly activated in about 50% of breast tumors, said Jiayuh Lin, the study's lead author and an associate professor of pediatrics at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.